SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A minor change in the total revenue was seen in the March 2022 quarter. The total revenue for the quarter stood at Rs. 707.48 millions against Rs. 706.08 millions during year ago period.Net profit declined -5.83% to Rs. 143.52 millions from Rs. 152.40 millions.A decline of 205.52 millions was observed in the OP in the quarter ended March 2022 from 245.12 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 707.48 706.08 0.20 2727.98 2834.73 -3.77 2727.98 2834.73 -3.77
Other Income 51.69 25.84 100.04 90.80 68.23 33.08 90.80 68.23 33.08
PBIDT 205.52 245.12 -16.16 817.28 1075.34 -24.00 817.28 1075.34 -24.00
Interest 0.52 0.09 477.78 0.95 1.00 -5.00 0.95 1.00 -5.00
PBDT 205.00 245.03 -16.34 816.33 1074.34 -24.02 816.33 1074.34 -24.02
Depreciation 25.34 24.35 4.07 95.61 90.06 6.16 95.61 90.06 6.16
PBT 179.66 220.68 -18.59 720.72 984.28 -26.78 720.72 984.28 -26.78
TAX 36.14 68.28 -47.07 175.61 274.16 -35.95 175.61 274.16 -35.95
Deferred Tax -3.52 13.46 -126.15 -4.56 25.72 -117.73 -4.56 25.72 -117.73
PAT 143.52 152.40 -5.83 545.11 710.12 -23.24 545.11 710.12 -23.24
Equity 223.60 223.46 0.06 223.60 223.46 0.06 223.60 223.46 0.06
PBIDTM(%) 29.05 34.72 -16.32 29.96 37.93 -21.02 29.96 37.93 -21.02

Advanced Enzyme Share Price

299.15 0.30 (0.10%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×